Gemphire Therapeutics Inc.  [  NASDAQ ]  [ GEMP ]


17199 N. LAUREL PARK DRIVE
SUITE 401
LIVONIA,  MI,
  USA
248-980-6538
Filing DateCurrent and former namesChanged on date
2015-04-08
Gemphire Therapeutics Inc.
Central Index Key (CIK)
0001638287
State of Incorporation
DE
Country of Incorporation
USA
Fiscal year end
1231
IRS #
472389984
Std. Industrial Class.
2834 PHARMACEUTICAL PREPARATIONS

Ownership (Form 3,4,5)# Filings
Bisgaier Charles PhD (0001381030) 3
Golden Lee Scott (0001686217) 3
Gullans Steven R PhD (0001571997) 5
Hawryluk P Kent (0001673991) 4
KOUSKY KENNETH W (0000939478) 4
LICHTINGER PEDRO (0001470741) 4
Lowenschuss David (0001674050) 3
MATHIESEN JEFFREY S (0001296853) 3
Oniciu Carmen Daniela (0001673972) 3
Reno Seth (0001674004) 3
SASSINE ANDY (0001515322) 4
Sooch Mina (0001674006) 5
All related persons/companies# Filings
ADAGE CAPITAL PARTNERS GP, L.L.C. (0001165408) 1
Bisgaier Charles PhD (0001381030) 4
Cormorant Asset Management, LLC (0001583977) 1
Excel Venture Fund II, L.P. (0001538240) 1
Exchange Capital Management, Inc. (0001317733) 1
Golden Lee Scott (0001686217) 3
Gullans Steven R. Ph.D. (0001571997) 5
Hawryluk P. Kent (0001673991) 4
KOUSKY KENNETH W (0000939478) 4
LICHTINGER PEDRO (0001470741) 4
Lowenschuss David (0001674050) 4
MATHIESEN JEFFREY S (0001296853) 3
Oniciu Carmen Daniela (0001673972) 3
PFIZER CHARLES & CO INC 1
PFIZER INC (0000078003) 1
Reno Seth (0001674004) 3
SASSINE ANDY (0001515322) 4
Sooch Mina (0001674006) 6
db